Cardiovascular risk reduction in high-risk pediatric populations

被引:14
作者
不详
机构
关键词
D O I
10.1542/peds.2006-3557
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
ON JULY 7, 2006, the American Academy of Pediatrics endorsed the following publication: Kavey REW, Allada V, Daniels SR, et al. Cardiovascular risk reduction in high- risk pediatric populations: a scientific statement from the American Heart Association Expert Panel on Population and Prevention Science; the Councils on Cardiovascular Disease in the Young, Epidemiology and Prevention, Nutrition, Physical Activity and Metabolism, High Blood Pressure Research, Cardiovascular Nursing, and the Kidney in Heart Disease; and the Interdisciplinary Working Group on Quality of Care and Outcomes Research - endorsed by the American Academy of Pediatrics.
引用
收藏
页码:618 / 621
页数:4
相关论文
共 50 条
[31]   Detection of COPD in high-risk populations [J].
Gourgoulianis, KI ;
Hristou, K ;
Molyvdas, PA .
CHEST, 2002, 121 (05) :1721-1721
[32]   STUDIES OF POPULATIONS AT HIGH-RISK FOR ALCOHOLISM [J].
SCHUCKIT, MA .
PSYCHIATRIC DEVELOPMENTS, 1985, 3 (01) :31-63
[33]   STUDIES OF POPULATIONS AT HIGH-RISK FOR ALCOHOLISM [J].
SCHUCKIT, MA .
ALCOHOL AND ALCOHOLISM, 1986, 21 (02) :A4-A4
[34]   Infection in high-risk populations - Preface [J].
Khardori, Nancy ;
Khardori, Romesh .
INFECTIOUS DISEASE CLINICS OF NORTH AMERICA, 2007, 21 (03) :XIII-XIV
[35]   PRIMARY PREVENTION AND HIGH-RISK POPULATIONS [J].
DANDREA, M .
PERSONNEL AND GUIDANCE JOURNAL, 1984, 62 (09) :554-558
[36]   ESOPHAGEAL CANCER IN HIGH-RISK POPULATIONS [J].
RAAFAT, F .
LANCET, 1982, 1 (8280) :1077-1077
[37]   Cost-effectiveness of rosuvastatin for cardiovascular prevention in high-risk populations in Sweden [J].
Jonsson, L. ;
Ekman, M. ;
Karlsson, G. ;
Brun, J. .
VALUE IN HEALTH, 2006, 9 (06) :A346-A346
[38]   Discharge Discrepancies: Impact on High-Risk Medications, High-Risk Populations, and Readmission Rates [J].
Wynne, Jacob ;
Slavens, Jenny ;
Rogers, Jenelle .
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2025, 82 :S574-S574
[39]   High urinary levels of resveratrol metabolites are associated with a reduction in the prevalence of cardiovascular risk factors in high-risk patients [J].
Zamora-Ros, Raul ;
Urpi-Sarda, Mireia ;
Lamuela-Raventos, Rosa M. ;
Angel Martinez-Gonzalez, Miguel ;
Salas-Salvado, Jordi ;
Aros, Fernando ;
Fito, Montserrat ;
Lapetra, Jose ;
Estruch, Ramon ;
Andres-Lacueva, Cristina .
PHARMACOLOGICAL RESEARCH, 2012, 65 (06) :615-620
[40]   The cardiovascular polypill in high-risk patients [J].
Lafeber, Melvin ;
Spiering, Wilko ;
Singh, Kavita ;
Guggilla, Rama K. ;
Patil, Vinodvenkatesh ;
Webster, Ruth .
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2012, 19 (06) :1234-1242